scispace - formally typeset
Open AccessJournal ArticleDOI

An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering.

TLDR
The ensemble nature of macromolecular structure can elucidate allosteric mechanisms and open new doors for long-range control of protein function by combining multiple-temperature X-ray crystallography experiments and structure determination from hundreds of individual small-molecule fragment soaks.
Abstract
Proteins perform many important jobs in each of the cells in our bodies, such as transporting other molecules and helping chemical reactions to occur. The part of the protein directly involved in these tasks is called the active site. Other areas of the protein can communicate with the active site to switch the protein on or off. This method of control is known as allostery. Switching proteins on and off could help us to develop treatments for certain diseases. For example, a protein called PTP1B reduces how well cells can respond to insulin. Switching this protein off could therefore help to treat diabetes. However, much like it’s hard to guess how a light switch is wired to a light bulb without seeing behind the walls, it is hard to predict which remote areas of a protein are ‘wired’ to the active site. Keedy, Hill et al. have now used two complementary methods to examine the structure of PTP1B and find new allosteric sites. The first method captured a series of X-ray images from crystallized molecules of the protein held at different temperatures. This revealed areas of PTP1B that can move like windshield wipers to communicate with each other. The second method soaked PTP1B crystals in trays with hundreds of drug-sized molecules and assessed which sites on the protein the molecules bound to. The molecules generally bound to just a few sites of the protein. Further tests on one of these sites showed that it can communicate with the active site to turn the protein on or off. Further work will be needed to develop drugs that could treat diabetes by binding to the newly identified allosteric sites in PTP1B. More generally, the methods developed by Keedy, Hill et al. could be used to study allostery in other important proteins.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application.

TL;DR: The discovery of allosteric inhibitors has inspired a novel approach to selectively target SHP2 via the non-catalytic site, and the development of non-Allosteric/allosteric SHp2 inhibitors in recent years is discussed.
Journal ArticleDOI

Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.

TL;DR: In this article, a massive crystallographic screening and computational docking effort, identifying new chemical matter primarily targeting the active site of the macrodomain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported.
Journal ArticleDOI

Advances in covalent drug discovery

TL;DR: Covalent drugs have been used to treat diseases for more than a century, but tools that facilitate the rational design of covalent drug have emerged more recently as discussed by the authors , and the purposeful addition of reactive functional groups to existing ligands can enable potent and selective inhibition of target proteins, as demonstrated by the Covalent epidermal growth factor receptor (EGFR) and Bruton's tyrosine kinase (BTK) inhibitors used for treating various cancers.
Journal ArticleDOI

Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2

TL;DR: NMR measurements and X-ray crystallography show that wild-type SHP2 dynamically exchanges between a closed inactive conformation and an open activated form and that the oncogenic E76K mutation shifts the equilibrium to the open state, which is reversed by binding of the allosteric inhibitor SHP099.
Journal ArticleDOI

Revealing enzyme functional architecture via high-throughput microfluidic enzyme kinetics.

TL;DR: HT-MEK, a microfluidic platform for high-throughput, quantitative biochemistry, reveals enzyme architectures shaping function by revealing spatially contiguous “regions” of residues linked to particular aspects of function.
References
More filters
Journal ArticleDOI

The Protein Data Bank

TL;DR: The goals of the PDB are described, the systems in place for data deposition and access, how to obtain further information and plans for the future development of the resource are described.
Journal ArticleDOI

Features and development of Coot.

TL;DR: Coot is a molecular-graphics program designed to assist in the building of protein and other macromolecular models and the current state of development and available features are presented.
Journal ArticleDOI

Phaser crystallographic software

TL;DR: A description is given of Phaser-2.1: software for phasing macromolecular crystal structures by molecular replacement and single-wavelength anomalous dispersion phasing.
Related Papers (5)